http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2495659-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a3207aa09e52f47ab02e37dd7d62c587
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ffb254dcc29b6e3af35a16d3d2bbca1
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F8-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
filingDate 2011-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39354567bcfddfb62f23f9bc77ab5636
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0332a1f431d5505adbc2f5c3f6d1308
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85c54f6926a49c71c3e6a9186222d7df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42198b22b76a75b195e64b158d313e53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54c0bd295e76770cf6aa3d8008b194ce
publicationDate 2013-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2495659-C2
titleOfInvention Method for preparing laevomycetin ointment with glutaric aldehyde and aethonium
abstract FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to a method for preparing laevomycetin ointment with glutaric aldehyde and ethonium on the basis of modified laevomycetin, consisting in the fact that laevomycetin 100 mg/ml detoxified and polymerised at first in glutaric aldehyde 0.1-0.2% at 38-40°C for 3-5 days, then in 0.2% ethonium at 38-40°C for 2-3 days, is used for preparing 1-3% Vaseline ointment. n EFFECT: preparing the ointment with low toxicity and high bactericidal activity. n 3 ex
priorityDate 2011-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2400218-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005019404-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2360697-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453112611
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66895
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512889
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485535
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426754013
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656580
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID59025
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID59025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533513
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16399516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5959
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415767435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280980

Total number of triples: 43.